" /> Congenital disorder of glycosylation, type iic - CISMeF





Preferred Label : Congenital disorder of glycosylation, type iic;

Symbol : CDG2C;

CISMeF acronym : CDG IIC; CDG2C;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : RHS; Rambam-hasharon syndrome; CDGIIc; LAD2; Leukocyte adhesion deficiency, type II; Cdg iic;

Description : Congenital disorder of glycosylation type IIc (CDG2C) is an autosomal recessive disorder characterized by moderate to severe psychomotor retardation, mild dysmorphism, and impaired neutrophil motility. It is a member of a group of disorders with a defect in the processing of protein-bound glycans. For a general overview of congenital disorders of glycosylation (CDGs), see CDG1A (212065) and CDG2A (212066). The neutrophil defect in CDG2C has been referred to as 'leukocyte adhesion deficiency type II' (LAD2), which is a manifestation of the disorder; there are no cases of 'primary' LAD II (Frydman, 1996). Etzioni and Harlan (1999) provided a comprehensive review of both LAD1 (116920) and LAD2. While the functional neutrophil studies are similar in the 2 LADs, the clinical course is milder in LAD2. Furthermore, patients with LAD2 present other abnormal features, such as growth and mental retardation, which are related to the primary defect in fucose metabolism. Delayed separation of the umbilical cord occurs in LAD1.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the solute carrier family 35, member C1 gene (SLC35C1, 605881.0001);

Laboratory abnormalities : Neutrophilia, both basal and during infections;

Prefixed ID : #266265;

Details


You can consult :


Nous contacter.
17/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.